0A9B logo

SYNLAB AG Stock Price

LSE:0A9B Community·€2.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

0A9B Share Price Performance

€12.80
1.56 (13.88%)
€12.80
1.56 (13.88%)
Price €12.80

0A9B Community Narratives

There are no narratives available yet.

Recent 0A9B News & Updates

SYNLAB AG Key Details

€2.6b

Revenue

€604.9m

Cost of Revenue

€2.0b

Gross Profit

€1.9b

Other Expenses

€89.3m

Earnings

Last Reported Earnings
Mar 31, 2024
Next Reporting Earnings
n/a
Earnings per share (EPS)
0.41
Gross Margin
76.87%
Net Profit Margin
3.42%
Debt/Equity Ratio
39.0%

SYNLAB AG Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Adequate balance sheet and fair value.

3 Risks
2 Rewards

About 0A9B

Founded
1998
Employees
27000
CEO
Mathieu Floreani
WebsiteView website
www.synlab.ag

SYNLAB AG provides medical diagnostic services and specialty testing services in Europe. It also offers diagnostics for veterinary medicine. The company serves hospitals, practicing doctors, clinics, patients, governments, and corporations. SYNLAB AG was founded in 1998 and is headquartered in Munich, Germany.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

German Market Performance

  • 7 Days: 2.7%
  • 3 Months: 0.3%
  • 1 Year: 14.6%
  • Year to Date: 13.3%
Over the last 7 days, the market has risen 2.7%, driven by gains in every sector, especially the Industrials sector. In the last year, the market has climbed 15%. Earnings are forecast to grow by 17% annually. Market details ›